Virtu KCG Holdings’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Virtu KCG Holdings’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$775K	Buy	6,399 +4,393	+219%	+$509K	0.02%	767
2017 Q1	$227K	Sell	2,006 -8,684	-81%	-$1.01M	0.01%	2290
2016 Q4	$1.16M	Buy	10,690 +8,514	+391%	+$1.01M	0.03%	643
2016 Q3	$358K	Sell	2,176 -16,893	-89%	-$2.66M	0.01%	1735
2016 Q2	$2.72M	Buy	19,069 +5,740	+43%	+$837K	0.06%	206
2016 Q1	$1.71M	Buy	13,329 +6,926	+108%	+$818K	0.05%	329
2015 Q4	$956K	Buy	+6,403	New	+$1.08M	0.02%	902
2015 Q3	–	Sell	-2,079	Closed	-$502K	–	3933
2015 Q2	$502K	Buy	+2,079	New	+$554K	0.01%	1485
2014 Q4	–	Sell	-4,242	Closed	-$1M	–	4343
2014 Q3	$1M	Buy	4,242 +3,068	+261%	+$782K	0.02%	961
2014 Q2	$278K	Buy	+1,174	New	+$309K	﹤0.01%	2661

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Virtu KCG Holdings's ICPT Position: Q2 2017 in Review

Virtu KCG Holdings increased its Intercept Pharmaceuticals, Inc. (ICPT) stake by 219% in Q2 2017, buying an estimated $509K and bringing the position to 6,399 shares worth $775K. The position accounts for 0.02% of the portfolio, ranked #767.

Virtu KCG Holdings first reported a position in ICPT in Q2 2014 and has held it in 10 quarters since. The position peaked at $2.72M in Q2 2016. 167 funds tracked by Wall St. Rank hold ICPT as of Q2 2017.

Virtu KCG Holdings held 6,399 shares of Intercept Pharmaceuticals, Inc. worth $775K as of Q2 2017.
Virtu KCG Holdings bought 4,393 Intercept Pharmaceuticals, Inc. shares in Q2 2017, an estimated $509K.
Intercept Pharmaceuticals, Inc. made up 0.02% of Virtu KCG Holdings's portfolio in Q2 2017, its #767 holding.
Virtu KCG Holdings first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2014 and has held it in 10 quarters since.
Virtu KCG Holdings's Intercept Pharmaceuticals, Inc. position peaked at $2.72M in Q2 2016.
167 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.